7 August 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Ofatumumab results published
A potential new disease modifying drug (DMD) for relapsing remitting MS reduced relapses by a little over half compared to another DMD (Aubagio), according to newly published results. Ofatumumab also reduced disability worsening at three and six months and disease activity on MRI scans
MS Trust link: Ofatumumab (Arzerra)
Nerve protecting mechanism identified
Researchers in Edinburgh have identified a natural mechanism that protects myelin from damage. Research in mice has found that this can be enhance using a diabetes drug called pioglitazone, which may protect nerves from further damage. More trials will be needed to establish how this might work in humans
MS Trust link: Neuroprotection
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.